NCT05222750View on ClinicalTrials.gov

Epidemiology of Thrombotic Thrombocytopenia Syndrome in Integrated Health-care Database in England

CompletedOBSERVATIONAL
Enrollment

41,200,246

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

May 25, 2023

Study Completion Date

May 25, 2023

Conditions
COVID-19
Interventions
OTHER

Pre-COVID-19

Pre-COVID-19

OTHER

COVID-19

COVID-19

OTHER

COVID-19 vaccination roll-out

COVID-19 vaccination roll-out

Trial Locations (1)

OX12JD

Research Site, Oxford

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY